Array Biopharma Inc (NASDAQ:ARRY)

Delayed Data
As of Mar 27
 +0.07 / +0.95%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Array Biopharma Inc have a median target of 10.00, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +35.14% increase from the last price of 7.40.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Array Biopharma Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -216.67%
Growthannually 89.86%


Growthquarterly -77.72%
Growthannually 4.18%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account